ACM Research, Inc. (ACMR) 2025 Annual Report Summary
Business Context and Reporting Period
This summary covers the fiscal year ended December 31, 2025, for ACM Research, Inc. (ACMR), a Delaware corporation supplying advanced capital equipment for the global semiconductor industry. The company operates principally through its subsidiary, ACM Research (Shanghai), Inc. (ACM Shanghai), which is listed on the Shanghai STAR Market. ACM Research holds a 74.6% ownership interest in ACM Shanghai following a private offering in September 2025. The company focuses on wet-cleaning, plating, furnace, PECVD, and advanced packaging equipment, with the majority of revenue derived from customers in mainland China.
Key Financial Metrics
| Metric | 2025 | 2024 | 2023 |
|---|---|---|---|
| Total Revenue | $901.3 million | $782.1 million | $557.7 million |
| Gross Profit | $400.1 million | $391.6 million | $276.2 million |
| Gross Margin | 44.4% | 50.1% | 49.5% |
| Net Income (Consolidated) | $121.9 million | $131.3 million | $96.9 million |
| Net Income Attributable to ACMR | $94.1 million | $103.6 million | $77.3 million |
| Diluted EPS | $1.37 | $1.53 | $1.16 |
| Operating Cash Flow | ($10.3 million) | $152.5 million | ($75.3 million) |
| Cash & Equivalents (End of Period) | $1.13 billion | $441.9 million | N/A |
| Total Debt (Short & Long Term) | $288.1 million | $182.8 million | N/A |
Material Changes vs. Prior Period
- Revenue Growth: Revenue increased 15.2% year-over-year to $901.3 million, driven by higher sales of single wafer cleaning equipment (up 8.1%), ECP and furnace technologies (up 32.1%), and advanced packaging services (up 45.3%).
- Margin Compression: Gross margin declined 570 basis points to 44.4%, primarily due to product mix shifts and a higher inventory provision ($15.5 million in 2025 vs. $2.8 million in 2024).
- Operating Expenses: Total operating expenses rose 20.8% to $290.6 million. R&D expenses increased 37.5% to $145.0 million due to higher component costs for tool development and personnel costs, partially offset by a decrease in stock-based compensation.
- Liquidity Surge: Cash and cash equivalents increased by $690.7 million to $1.13 billion, largely driven by $623.0 million in net proceeds from ACM Shanghai's private offering and $206.7 million in net borrowings.
- Non-GAAP Metrics: Adjusted EBITDA decreased 27.0% to $160.0 million, reflecting lower operating income and reduced stock-based compensation.
Guidance, Outlook, Risks, and Unusual Items
- Regulatory Risks (BIS Entity List): In December 2024, ACM Shanghai and ACM Korea were added to the U.S. Bureau of Industry and Security (BIS) Entity List. This prohibits U.S. persons from furnishing hardware, software, or technology subject to U.S. export controls without authorization. Management believes the impact can be managed but acknowledges risks to supply chains and production plans.
- Outbound Investment Restrictions: The U.S. Outbound Investment Security Program (OISP) and the COINS Act (signed Dec 2025) impose restrictions on U.S. investments in Chinese semiconductor sectors. While the COINS Act may exempt ACM Research from certain private investment restrictions once implemented (2026-2027), regulatory burdens remain.
- Customer Concentration: Four customers accounted for 52.2% of revenue in 2025. The company relies heavily on the capital spending of Chinese chip manufacturers.
- Subsequent Event: In February 2026, ACM Research sold 4.8 million shares of ACM Shanghai on the STAR Market at RMB 160.00 per share.
- Legal Proceedings: ACM Korea is facing a customs investigation in Seoul regarding goods shipped to overseas markets. A fine was paid and appealed; management does not believe this will have a material effect on financial condition.
Key Facts for Investor Verification
- Supply Chain Resilience: Verify the company's ability to source critical components from non-U.S. suppliers following the BIS Entity List designation and the transition of U.S.-origin components.
- Inventory Valuation: Review the $15.5 million inventory provision and the $702.6 million total inventory balance, noting that $145.5 million represents "first tools" at customer sites awaiting acceptance.
- Regulatory Compliance: Monitor ongoing developments regarding the HFCA Act, PCAOB inspections of the Chinese auditor (Ernst & Young Hua Ming LLP), and potential delisting risks.
- Revenue Recognition: Understand the distinction between "repeat shipments" (revenue recognized on delivery) and "first tools" (revenue recognized upon acceptance), which impacts cash flow timing.
- Dividend Policy: Confirm that ACM Research does not intend to pay cash dividends, as earnings are retained for operations and growth, and repatriation of funds from China is subject to regulatory restrictions.